A phase 1 study of denintuzumab mafodotin (SGN-CD19A) in relapsed/refactory B-lineage non-Hodgkin lymphoma Meeting Abstract


Authors: Moskowitz, C. H.; Fanale, M. A.; Shah, B. D.; Advani, R. H.; Chen, R.; Kim, S.; Kostic, A.; Liu, T. N.; Peng, J.; Forero-Torres, A.
Abstract Title: A phase 1 study of denintuzumab mafodotin (SGN-CD19A) in relapsed/refactory B-lineage non-Hodgkin lymphoma
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368019000246
PROVIDER: wos
DOI: 10.1182/blood.V126.23.182.182
Notes: Meeting Abstract: 182 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Craig Moskowitz
    407 Moskowitz